News & Articles
Selected Filters:
InSphero Launches Industry’s First Automation-Compatible 3D Human Liver Disease Platform for NASH Drug Discovery and Screening
3D InSight Human Liver Disease platform provides the most physiologically relevant testing environment for efficacy and safety
InSphero Launches Multi-Donor Human Liver Microtissues for Prediction of Drug-Induced Liver Injury
3D human liver microtissues comprised of pooled hepatocytes from multiple donors offers more genetically diverse model for DILI detection and prediction
InSphero Contributes 3D Microtissue-based Assay Chapter to NCATS/NIH Assay Guidance Manual
Latest update of industry manual for development of high-throughput screening assays calls on scientists from leading 3D cell culture provider for standardized viability, toxicity protocols.
InSphero and NCATS to Present Collaborative 3D Cancer Screening Study at SLAS2016 Annual Meeting
InSphero and NCATS to Present Collaborative 3D Cancer Screening Study at SLAS2016 Annual Meeting
InSphero Expands Global Availability of its Patented 3D Cell Culture Platforms
PerkinElmer named as exclusive distributor of InSphero state-of-the-art 3D culture technology
InSphero Launches Enhanced Ultra-low Attachment Spheroid Plate for Scaffold-free 3D Cell Culture
GravityTRAP™ ULA Plate design simplifies medium exchange and improves imaging during spheroid production and culture.